Crinetics Pharmaceuticals, Inc. CRNX
- atumelnant — Congenital Adrenal Hyperplasia Phase 2
- atumelnant — ACTH-Dependent Cushing's Syndrome Phase 1
- atumelnant — Adrenal Crisis Phase 2
Home › Targets › ACTH receptor
ACTH receptor (1 companies · 3 programs)
Companies with an active program directed at ACTH receptor.